View of Immunogenetic study of programmed death-ligand 1 variation and hepatitis B virus in Iraqi patients with chronic myeloid leukemia | Anaesthesia, Pain & Intensive Care

Return to Article Details Immunogenetic study of programmed death-ligand 1 variation and hepatitis B virus in Iraqi patients with chronic myeloid leukemia